Nalbin infusion dose in acute liver failure
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
"Nalbin" is a brand name for N-acetylcysteine (NAC) used primarily in South Asian countries (India, Pakistan). Here is the complete dosing information from authoritative sources:
Nalbin (N-Acetylcysteine) Infusion in Acute Liver Failure
Mechanism
NAC acts as a glutathione precursor and sulfhydryl donor, replenishing hepatic glutathione stores and neutralizing toxic metabolites (especially NAPQI in acetaminophen toxicity). It also improves microcirculatory blood flow and oxygen delivery to the liver.
Indications in Acute Liver Failure
| Cause | Evidence |
|---|---|
| Acetaminophen (paracetamol) toxicity | Strong — first-line, most benefit within 8 h but partially effective up to 24–36 h |
| Idiosyncratic drug-induced liver injury | Limited data; commonly recommended |
| Acute hepatitis B | Commonly recommended |
| Autoimmune hepatitis | Commonly recommended |
| Indeterminate cause (especially grade 1–2 encephalopathy) | Commonly recommended |
IV Dosing Protocol
For Acetaminophen-Induced Acute Liver Failure:
| Phase | Dose | Duration |
|---|---|---|
| Loading dose | 150 mg/kg in 200 mL 5% dextrose | Over 60 minutes |
| Second phase | 50 mg/kg in 500 mL 5% dextrose | Over 4 hours |
| Third phase (maintenance) | 100 mg/kg in 1000 mL 5% dextrose | Over 16 hours |
This is the standard "Prescott" 3-bag protocol (total 300 mg/kg over 21 hours), widely used in clinical practice.
Alternative oral/simplified IV regimen (Goldman-Cecil / Harrison's):
- Loading: 140 mg/kg over 1 hour
- Maintenance: 70 mg/kg every 4 hours for 15–20 doses
For Non-Acetaminophen Acute Liver Failure
- Same IV NAC infusion is used (140 mg/kg loading + 70 mg/kg q4h)
- Benefit is most pronounced in patients with grade 1–2 hepatic encephalopathy
- A landmark RCT (Lee et al., Gastroenterology 2009) showed improved transplant-free survival in early-stage non-acetaminophen ALF
Practical Points
- Administer in an ICU setting
- Monitor for anaphylactoid reactions (more common with IV route): flushing, urticaria, bronchospasm — usually manageable by slowing the infusion rate
- Treatment can be stopped when acetaminophen plasma levels indicate low risk of liver damage
- If signs of hepatic failure progress despite NAC therapy, liver transplantation should be considered
Sources: Goldman-Cecil Medicine, 26th ed. | Harrison's Principles of Internal Medicine, 22nd ed. (2025)
This is a shared conversation. Sign in to Orris to start your own chat.